Illumina, Inc. Announces 3.5 Million Share Public Offering
Published: Aug 04, 2008
Goldman, Sachs & Co. is acting as sole manager of the offering.
This communication is not an offer to sell or the solicitation of an offer to buy these securities, nor will there be any sale of these securities in any state in which such offer, solicitation or sale is not permitted. Copies of the preliminary prospectus supplement and accompanying prospectus may be obtained from the Prospectus Department of Goldman, Sachs & Co., 00 Burma Road, Jersey City, NJ 07305. Phone: 212-902-1171, Facsimile: 212-902-9316, and e-mail at email@example.com.
Illumina develops and markets next-generation tools for the large-scale analysis of genetic variation and function.
Investors: Christian Henry Sr. Vice President & CFO 858-202-4508 firstname.lastname@example.org or Peter J. Fromen Sr. Director, Investor Relations 858-202-4507 email@example.com or Media: Maurissa Bornstein Public Relations Manager 858-332-4055 firstname.lastname@example.org http://www.illumina.com/